June 22, 2012 / 7:01 AM / in 5 years

Astellas gets expanded approval for Symbicort asthma drug in Japan

TOKYO, June 22 (Reuters) - Astellas Pharma Inc said on Friday it has received approval for additional use of its Symbicort Turbuhaler drug treatment for adult bronchial asthma in Japan beyond its current twice-daily usage limit.

Users in Japan can now use Symbicort, launched in Japan in January 2010, at the onset of an asthma attack and take one further inhalation after a few minutes if the attack continues, Astellas said. (Reporting by Mayumi Negishi; Editing by Michael Watson)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below